Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -67.80%978.78K | 45.67%16.03M | -24.51%3.94M | 27.92%3.32M | 99.40%3.77M | 43.57%3.04M | -7.00%11M | 95.55%5.22M | 8.46%2.6M | -45.42%1.89M |
| Cost of revenue | -56.61%952.25K | 52.93%10.58M | -25.84%2.74M | 6.92%1.96M | 55.14%1.68M | 60.56%2.19M | -29.33%6.92M | 100.85%3.7M | -6.68%1.84M | -57.36%1.08M |
| Gross profit | -96.86%26.53K | 33.37%5.45M | -21.29%1.2M | 78.73%1.36M | 158.85%2.09M | 12.62%845.01K | 100.30%4.08M | 83.75%1.52M | 78.50%759.13K | -12.56%806.64K |
| Operating expense | 8.82%844.59K | -15.29%2.53M | -32.56%508.83K | 34.10%876.35K | 13.65%1.11M | 15.09%776.15K | -11.22%2.98M | -17.05%754.51K | -21.41%653.52K | 13.72%973.71K |
| Selling and administrative expenses | 13.49%459.21K | 10.53%4.84M | -25.76%389.14K | 11.76%397.37K | -2.67%505.26K | 5.59%404.64K | 25.25%4.38M | -75.36%524.19K | -17.64%355.54K | -0.90%519.1K |
| -Selling and marketing expense | -29.14%36.08K | 58.21%259.66K | -53.35%15.25K | 272.17%71.46K | -26.65%36.39K | -18.69%50.92K | --164.13K | --32.69K | -76.81%19.2K | -31.36%49.61K |
| -General and administrative expense | 19.62%423.12K | 10.53%4.84M | -23.93%373.89K | -3.10%325.91K | -0.13%468.87K | 10.33%353.72K | 25.25%4.38M | -78.92%491.5K | -3.60%336.34K | 3.98%469.49K |
| Other operating expenses | 4.57%440.95K | 225.14%240.19K | 127.31%781.52K | 21.47%533.02K | 35.69%658.59K | 22.18%421.7K | ---191.94K | --343.81K | 1.21%438.79K | 33.15%485.37K |
| Total other operating income | 10.72%55.57K | 112.32%2.55M | 483.15%661.84K | -61.63%54.04K | 86.09%57.26K | -7.05%50.19K | 797.50%1.2M | 200.66%113.49K | 317.86%140.82K | -4.31%30.77K |
| Operating profit | -1,287.97%-818.06K | 165.28%2.92M | -10.19%688.28K | 354.92%480.45K | 687.43%981.42K | -9.36%68.86K | 183.29%1.1M | 1,035.63%766.35K | 126.00%105.61K | -351.82%-167.07K |
| Net non-operating interest income (expenses) | 84.71%-1.09K | 89.09%-7.15K | 0 | 0 | 0 | 51.29%-7.15K | 12.89%-65.55K | 59.12%-17.09K | -25.25%-16.11K | -74.68%-17.67K |
| Non-operating interest expense | -84.71%1.09K | -89.09%7.15K | --0 | --0 | --0 | -51.29%7.15K | -12.89%65.55K | -59.12%17.09K | 25.25%16.11K | 74.68%17.67K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 659.10%265.34K | -16.54%284.01K | 28.47%-222.58K | 19,219.08%260.59K | 505.97%249.31K | -176.87%-47.46K | 0.16%340.32K | -96.28%-311.18K | 97.25%-1.36K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -363.38%-819.15K | 221.79%3.18M | -10.76%972.29K | 216.33%257.87K | 767.37%1.24M | 263,675.42%311.02K | 173.98%987.48K | 404.28%1.09M | 61.63%-221.68K | -2,921.94%-186.11K |
| Income tax | 2,326.79%69.84K | 118.56%483.79K | -5.78%291.9K | 821.60%28.12K | 555.90%66.14K | -44.61%2.88K | 996.36%221.36K | 4,958.09%309.81K | -53.61%3.05K | 144.38%10.08K |
| Net income | -388.50%-889K | 251.61%2.69M | -12.74%680.39K | 202.23%229.75K | 699.35%1.18M | 5,898.66%308.14K | 156.54%766.13K | 271.42%779.77K | 61.54%-224.73K | -769.16%-196.19K |
| Net income continuous operations | -388.50%-889K | 251.61%2.69M | -12.74%680.39K | 202.23%229.75K | 699.35%1.18M | 5,898.66%308.14K | 156.54%766.13K | 271.42%779.77K | 61.54%-224.73K | -769.16%-196.19K |
| Noncontrolling interests | -19.85%-55.48K | 60.55%267.26K | -35.36%113.14K | 144.42%22.52K | 793.71%109.65K | -1,454.85%-46.29K | 642.48%166.46K | 1,493.11%175.02K | -327.45%-50.69K | 1,766.98%12.27K |
| Net income attributable to the company | -335.17%-833.52K | 304.65%2.43M | -6.20%567.26K | 219.07%207.23K | 611.48%1.07M | 15,265.98%354.43K | 145.28%599.66K | 203.96%604.75K | 69.59%-174.04K | -793.60%-208.46K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -335.17%-833.52K | 304.65%2.43M | -6.20%567.26K | 219.07%207.23K | 611.48%1.07M | 15,265.98%354.43K | 145.28%599.66K | 203.96%604.75K | 69.59%-174.04K | -793.60%-208.46K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -330.77%-0.003 | 286.96%0.0089 | -4.55%0.0021 | 233.33%0.0008 | 587.50%0.0039 | 14,544.44%0.0013 | 144.23%0.0023 | 175.00%0.0022 | 72.73%-0.0006 | -900.00%-0.0008 |
| Diluted earnings per share | -330.77%-0.003 | 286.96%0.0089 | -4.55%0.0021 | 233.33%0.0008 | 587.50%0.0039 | 14,544.44%0.0013 | 144.23%0.0023 | 182.41%0.0022 | 72.73%-0.0006 | -900.00%-0.0008 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.